2 withdrawn, 1 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Withdrawn 2, Completed 1 |
Follow Aurobindo Pharma Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacodynamic Bioequivalence Study of Albuterol Sulfate Inhalation Aerosol, 0.09 mg Albuterol Base/ Inhalation Methacholine Chloride, Albuterol Sulfate HFA 0.09 mg (Reference), Albuterol Sulfate HFA 0.18 mg (Reference) - Bronchial Asthma | Phase 3 | Withdrawn | Aurobindo Pharma Ltd | 2022-04-01 | 2022-05-20 | |
| Clinical Endpoint Bioequivalence Study of Adapalene Gel 0.1% Adapalene 0.1% Gel, Differin 0.1% Topical Gel, Placebo - Acne Vulgaris | Phase 3 | Withdrawn | Aurobindo Pharma Ltd | 2020-07-01 | 2020-06-26 | |
| Clinical Pharmacodynamic Bioequivalence Study of Beclomethasone Dipropionate 40 mcg INH Test Product, Reference Product, Placebo - Bronchial Asthma | Phase 3 | Completed | Aurobindo Pharma Ltd | 1550 | 2019-03-12 | 2020-11-13 |
Asthma (2) · Acne Vulgaris (1)
Adapalene (1) · Beclomethasone (1) · Gels (1) · Methacholine Chloride (1)
India (1) · United States (1)
Joseph Marialouis (1) · Joseph Marialouis, MD (1)